查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1965363

血液學市場－全球產業規模、佔有率、趨勢、機會、預測：試劑、產品、地區和競爭格局（2021-2031年）

Hematology Market - Global Industry Size, Share, Trends, Opportunity, & Forecast Segmented By Reagent, By Product, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球血液學市場預計將從 2025 年的 180.2 億美元成長到 2031 年的 254.1 億美元，複合年成長率為 5.89%。

該市場涵蓋醫療機構用於檢測、分析和監測血液疾病的專用診斷設備、試劑和耗材。該領域的成長主要受白血病和貧血等血液疾病發病率上升以及全球人口老化導致持續診斷監測需求增加的驅動。此外，臨床檢查室對高通量檢測的需求也推動了對自動化解決方案的持續需求，以確保為關鍵患者照護提供快速檢測結果。

市場概覽
預測期 2027-2031
市場規模：2025年 180.2億美元
市場規模：2031年 254.1億美元
複合年成長率：2026-2031年 5.89%
成長最快的細分市場 凝血試劑
最大的市場 北美洲

美國癌症協會在其2025年報告中強調了建立健全診斷基礎設施的迫切需求，並指出「預計美國白血病、淋巴瘤或骨髓瘤的確診患者總合將達到192,070人」。儘管有這些強勁的促進因素，市場仍面臨一個重大障礙：先進血液分析儀的高昂購買成本。這種經濟負擔限制了小規模醫療機構和新興經濟體採用這些儀器的普及率，構成了一項可能阻礙市場更廣泛擴張的重大挑戰。

市場促進因素

人工智慧 (AI) 與數位病理學的融合正在從根本上改變全球血液學市場，最佳化診斷準確性和工作流程效率。檢查室正擴大採用能夠自動識別和分類血球的 AI 演算法，從而顯著減少人工顯微鏡檢查所需的時間。這項技術變革不僅解決了熟練血液科醫生嚴重短缺的問題，還最大限度地減少了複雜診斷中的人為錯誤。例如，Scopio Labs 在 2025 年 7 月的新聞稿中宣布推出其 AI 驅動的「全血形態學」分析儀。這是第一個能夠完全自動化血球分析的解決方案，無需人工檢測，並迅速將數位血液學確立為行業標準。

同時，臨床檢測量激增的需求正在加速自動化高通量血液分析儀的普及應用。大型檢查室優先引進模組化自動化系統，將血液學檢測與其他領域整合，以提高營運效率並縮短結果報告時間。全球血液疾病帶來的巨大負擔進一步加劇了這項需求。例如，世界衛生組織（世衛組織）於2025年8月發布的《2025年全球貧血估計值：主要發現》報告顯示，到2023年，全球15至49歲女性中約有30.7%將患有貧血，需要持續的診斷監測。為了反映這項需求的激增，希森美康公司於2025年5月發布的《截至2025年3月的財政年度概要》報告稱，其全球合併銷售額成長了10.2%，主要得益於血液學領域儀器和試劑銷售額的成長。

市場挑戰

先進的血液分析儀需要大量的資金投入，這成為市場成長的主要障礙，尤其是在資源匱乏的環境中。這些診斷系統憑藉其自動化和高通量功能，價格昂貴，往往令小規模診所、區域醫療中心和新興經濟體的醫療機構難以負擔。因此，相當一部分潛在客戶無法從手動或半自動方法過渡到全自動解決方案，阻礙了現代血液學技術的應用，並限制了整體市場擴張。

這種財務壓力正直接影響醫療保健產業的採購行為和採購週期。預算限制迫使許多醫療機構延長現有設備的使用壽命，而不是投資新設備。美國醫院協會預測，到2025年，94%的醫療機構管理者將推遲設備升級以應對財務負擔，這印證了上述限制。這種普遍推遲購置資本設備的趨勢降低了舊有系統的更換速度，並導致全球血液學領域製造商的產生收入顯著下降。

市場趨勢

受重症監護領域對快速診斷需求的推動，全球血液學市場正向分散式和照護現場(POC) 解決方案轉型。這一趨勢包括攜帶式分析儀的推出，這些分析儀可在傳統實驗室之外提供實驗室級別的全血細胞計數，從而加速臨床檢驗。製造商正積極驗證這些平台，以滿足嚴格的監管標準。例如，PixCell Medical 在 2024 年 11 月的新聞稿中宣布，其 HemoScreen CBC 分析儀已成為首款獲得歐盟體外醫療設備法規 (IVDR) 認證的照護現場五類分析儀，證明了其在各種醫療環境中的實用性。

同時，個人化血液學診斷的興起正在透過將基因組分析與常規評估相結合，改變血液腫瘤的治療方式。醫療機構正在利用分子診斷來識別基因突變，從而實現針對急性骨髓性白血病(AML) 等疾病的標靶治療。這種方法透過根據疾病的生物學特徵量身定做治療方案，改善了治療效果。例如，根據白血病和淋巴瘤協會 2024 年 11 月發布的新聞稿《ASH 數據展望血液腫瘤治療的未來》，約有 1600 名 AML 患者在確診後七天內接受了基因組篩檢，加速了精準治療的實現。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球血液學市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 試劑類型（凝血試劑、流式細胞技術試劑、免疫血液學試劑、其他）
    • 副產物（血液分析儀、流式細胞儀、凝血分析儀、玻片染色儀）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美血液學市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲血液學市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太血液學市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲血液學市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲血液學市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球血液學市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Abbott Laboratories Inc.
  • F. Hoffmann-La Roche Ltd
  • Sysmex Corporation
  • Siemens Healthineers AG
  • Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • Boule Diagnostics AB
  • Nihon Kohden Corporation
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Diatron Medical Instruments Limited

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 24323

The Global Hematology Market is projected to expand from USD 18.02 Billion in 2025 to USD 25.41 Billion by 2031, achieving a CAGR of 5.89%. This market encompasses specialized diagnostic instruments, reagents, and consumables utilized by healthcare providers to detect, analyze, and monitor blood disorders. The sector's growth is primarily driven by the rising prevalence of hematologic diseases, such as leukemia and anemia, alongside an aging global population that requires consistent diagnostic oversight. Additionally, the necessity for high-throughput testing in clinical laboratories fuels a steady demand for automated solutions to ensure faster turnaround times for critical patient care.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 18.02 Billion
Market Size 2031USD 25.41 Billion
CAGR 2026-20315.89%
Fastest Growing SegmentCoagulation Reagents
Largest MarketNorth America

Underscoring the urgent need for robust diagnostic infrastructure, the 'American Cancer Society' reported in '2025' that 'an estimated combined total of 192,070 people in the US are expected to be diagnosed with leukemia, lymphoma or myeloma'. Despite these strong drivers, the market faces a significant obstacle regarding the high capital costs associated with advanced hematology analyzers. This financial burden limits adoption rates among smaller healthcare facilities and within emerging economies, presenting a considerable challenge that could hinder broader market expansion.

Market Driver

The integration of Artificial Intelligence and digital pathology is fundamentally reshaping the Global Hematology Market by optimizing diagnostic precision and workflow efficiency. Laboratories are increasingly implementing AI algorithms that automatically identify and classify blood cells, which significantly reduces the time required for manual microscopic reviews. This technological shift addresses the critical shortage of skilled hematopathologists while minimizing human error in complex diagnoses. Validating this advancement, according to Scopio Labs, July 2025, in a company press release, the firm unveiled its AI-powered Complete Blood Morphology analyzer, a first-of-its-kind solution designed to fully automate the analysis of blood cells and eliminate the need for manual review, rapidly establishing digital hematology as a standard of care.

Simultaneously, the expansion of automated high-throughput hematology analyzers is being propelled by the urgent necessity to manage escalating testing volumes in clinical settings. High-volume laboratories are prioritizing modular automation tracks that integrate hematology with other disciplines to streamline operations and improve turnaround times. This demand is further amplified by the immense global burden of blood disorders; for instance, according to the World Health Organization, August 2025, in the 'WHO global anaemia estimates: key findings, 2025', approximately 30.7% of women aged 15-49 years worldwide suffered from anemia in 2023, necessitating consistent diagnostic monitoring. Reflecting this surge in demand, according to Sysmex Corporation, May 2025, in the 'Summary of Consolidated Financial Results for the Fiscal Year Ended March 31, 2025', global consolidated net sales increased by 10.2%, driven significantly by higher sales of instruments and reagents in the hematology field.

Market Challenge

The high capital investment required for advanced hematology analyzers constitutes a primary barrier to market growth, particularly in resource-constrained settings. These diagnostic systems, which offer automated and high-throughput capabilities, command premium prices that are often prohibitive for smaller clinics, community health centers, and facilities in emerging economies. Consequently, a significant portion of the potential customer base is unable to transition from manual or semi-automated methods to fully automated solutions, thereby stifling the broader adoption of modern hematology technologies and limiting overall market expansion.

This financial pressure directly impacts purchasing behaviors and procurement cycles within the healthcare sector. Budgetary constraints force many institutions to extend the lifespan of existing equipment rather than investing in newer models. Validating this constraint, according to 'American Hospital Association', in '2025', '94% of health care administrators expect to delay equipment upgrades to manage financial strain'. This widespread deferral of capital equipment acquisition slows the replacement rate of legacy systems and creates a measurable deceleration in revenue generation for manufacturers operating in the global hematology space.

Market Trends

The Global Hematology Market is shifting toward decentralized and point-of-care (POC) testing solutions, driven by the demand for rapid diagnostics in critical care. This trend involves deploying portable analyzers that deliver lab-quality complete blood counts outside traditional laboratories, accelerating clinical decision-making. Manufacturers are actively validating these platforms to meet rigorous regulatory standards. Validating this maturity, according to PixCell Medical, November 2024, in a company press release, its HemoScreen CBC analyzer became the first point-of-care 5-part differential analyzer to achieve certification under the EU's In Vitro Diagnostic Medical Devices Regulation (IVDR), confirming its readiness for diverse healthcare environments.

Concurrently, the rise of personalized hematology diagnostics is transforming blood cancer management by integrating genomic profiling with routine evaluation. Providers are adopting molecular diagnostics to identify genetic mutations, enabling targeted therapies for conditions like acute myeloid leukemia (AML). This approach improves outcomes by tailoring treatment to the disease's biological signature. Highlighting this adoption, according to The Leukemia & Lymphoma Society, November 2024, in the 'Data at ASH Provides Glimpse into the Future of Blood Cancer Treatment' press release, nearly 1,600 patients with AML have received genomic screening within seven days of diagnosis to facilitate precision treatment.

Key Market Players

  • Abbott Laboratories Inc.
  • F. Hoffmann-La Roche Ltd
  • Sysmex Corporation
  • Siemens Healthineers AG
  • Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • Boule Diagnostics AB
  • Nihon Kohden Corporation
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Diatron Medical Instruments Limited

Report Scope

In this report, the Global Hematology Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Hematology Market, By Reagent

  • Coagulation Reagents
  • Flow Cytometry Reagents
  • Immuno-hematology Reagents
  • Other

Hematology Market, By Product

  • Hematology Analyzers
  • Flow Cytometers
  • Coagulation Analyzers
  • Slide Stainers

Hematology Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Hematology Market.

Available Customizations:

Global Hematology Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Hematology Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Reagent (Coagulation Reagents, Flow Cytometry Reagents, Immuno-hematology Reagents, Other)
    • 5.2.2. By Product (Hematology Analyzers, Flow Cytometers, Coagulation Analyzers, Slide Stainers)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Hematology Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Reagent
    • 6.2.2. By Product
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Hematology Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Reagent
        • 6.3.1.2.2. By Product
    • 6.3.2. Canada Hematology Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Reagent
        • 6.3.2.2.2. By Product
    • 6.3.3. Mexico Hematology Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Reagent
        • 6.3.3.2.2. By Product

7. Europe Hematology Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Reagent
    • 7.2.2. By Product
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Hematology Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Reagent
        • 7.3.1.2.2. By Product
    • 7.3.2. France Hematology Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Reagent
        • 7.3.2.2.2. By Product
    • 7.3.3. United Kingdom Hematology Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Reagent
        • 7.3.3.2.2. By Product
    • 7.3.4. Italy Hematology Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Reagent
        • 7.3.4.2.2. By Product
    • 7.3.5. Spain Hematology Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Reagent
        • 7.3.5.2.2. By Product

8. Asia Pacific Hematology Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Reagent
    • 8.2.2. By Product
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Hematology Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Reagent
        • 8.3.1.2.2. By Product
    • 8.3.2. India Hematology Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Reagent
        • 8.3.2.2.2. By Product
    • 8.3.3. Japan Hematology Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Reagent
        • 8.3.3.2.2. By Product
    • 8.3.4. South Korea Hematology Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Reagent
        • 8.3.4.2.2. By Product
    • 8.3.5. Australia Hematology Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Reagent
        • 8.3.5.2.2. By Product

9. Middle East & Africa Hematology Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Reagent
    • 9.2.2. By Product
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Hematology Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Reagent
        • 9.3.1.2.2. By Product
    • 9.3.2. UAE Hematology Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Reagent
        • 9.3.2.2.2. By Product
    • 9.3.3. South Africa Hematology Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Reagent
        • 9.3.3.2.2. By Product

10. South America Hematology Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Reagent
    • 10.2.2. By Product
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Hematology Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Reagent
        • 10.3.1.2.2. By Product
    • 10.3.2. Colombia Hematology Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Reagent
        • 10.3.2.2.2. By Product
    • 10.3.3. Argentina Hematology Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Reagent
        • 10.3.3.2.2. By Product

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Hematology Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Abbott Laboratories Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. F. Hoffmann-La Roche Ltd
  • 15.3. Sysmex Corporation
  • 15.4. Siemens Healthineers AG
  • 15.5. Danaher Corporation
  • 15.6. Bio-Rad Laboratories, Inc.
  • 15.7. Boule Diagnostics AB
  • 15.8. Nihon Kohden Corporation
  • 15.9. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 15.10. Diatron Medical Instruments Limited

16. Strategic Recommendations

17. About Us & Disclaimer